Hepatitis C virus asialoglycoprotein-E1 and -E2; useful as vaccine or for diagnosis of non-A non-B hepatitis virus infection, or for concentrating or reducing HCV proteins in biological samples, and obtained by gene expression in yeast
Identifieur interne : 001B45 ( Main/Exploration ); précédent : 001B44; suivant : 001B46Hepatitis C virus asialoglycoprotein-E1 and -E2; useful as vaccine or for diagnosis of non-A non-B hepatitis virus infection, or for concentrating or reducing HCV proteins in biological samples, and obtained by gene expression in yeast
Auteurs :Source :
- Vaccine [ 0264-410X ] ; 1992.
English descriptors
- Teeft :
- Amino acid sequence, Asialoglycoprotein, Atcc, Attenuated, Avipox, Avipox virus, Biological fluids, Biological samples, Cattle vaccine, Chiron, Continual introduction, Corresponding f1pv peptides, Culturing, Different genogroups serotypes, Distemper, Distemper virus, Distemper virus virogenetics world, Encoding, F1pv, Fecv, Fecv disease, Fecvj, Fecvj optionally, Feline corona virus, Fipv, Fipv exposures, Fipv strains, Fusion partner, Fusion protein expression unit, Galactokinase, Galanthus, Galanthus nivalus agglutinin, Gene expression, Gene segments encoding, Genogroups, Genome, Genomic, Genomic segments, Glycoprotein, Glycosylation, Glycosylation signal, Glycosylationdeficient, Glycosylationdeficient yeast, Haemagglutinin, Hepatitis virus infection, Hepatitis virus infections, Heterotypic, Heterotypic nonhuman animal rotavirus vaccine, Host animal inoculated, Host cell, Hrvs, Human rotavirus, Human rotaviruses, Immunological, Immunological response, Inoculated, Inoculating, Inst, Mannose, Mannose receptor, Measles, Measles virus, Measles virus glycoprotein, Measles virus haemagglutinin glycoprotein, Measles virus haemagglutinin glycoprotein measles virus fusion protein, Morbilli, Morbilli virus, Multiple serotypes, Native fipv exposure, Neutralizing, Neutralizing antibodies, Nivalus, Nonessential, Nonessential region, Nonhuman, Novel method, Novel rotaviruses, Novel vaccines, Optionally, Parental strains, Patent report virus disease, Peptide, Plasmid, Plasmid potskf3, Potskf3, Primary vaccination, Receptor, Recombinant, Recombinant expression, Recombinant protein, Recombinant vaccine, Regulator sequence, Regulatory sequence, Revaccinating, Rotavirus, Rotavirus illness, Rotavirus strains, Rutavirus, Rutavirus illnesses gamble inst, Selectable, Selectable marker, Serotypes, Sialylate, Sialylate glycoproteins, Structural gene encoding, Such vaccines, Tier, Vaccinated, Vaccinated animals, Vaccine, Vaccinia, Vaccinia virus, Virogenetics, Virus, Virus genome, Yeast chiron world.
Url:
DOI: 10.1016/0264-410X(92)90123-2
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000087
- to stream Istex, to step Curation: 000055
- to stream Istex, to step Checkpoint: 000541
- to stream Main, to step Merge: 001B63
- to stream Main, to step Curation: 001B45
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Hepatitis C virus asialoglycoprotein-E1 and -E2; useful as vaccine or for diagnosis of non-A non-B hepatitis virus infection, or for concentrating or reducing HCV proteins in biological samples, and obtained by gene expression in yeast</title>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:5B2F569956BF6BAE84DAF5C7D65E68D9BC1708F6</idno>
<date when="1992" year="1992">1992</date>
<idno type="doi">10.1016/0264-410X(92)90123-2</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-VBJP2WNJ-F/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000087</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000087</idno>
<idno type="wicri:Area/Istex/Curation">000055</idno>
<idno type="wicri:Area/Istex/Checkpoint">000541</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000541</idno>
<idno type="wicri:Area/Main/Merge">001B63</idno>
<idno type="wicri:Area/Main/Curation">001B45</idno>
<idno type="wicri:Area/Main/Exploration">001B45</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Hepatitis C virus asialoglycoprotein-E1 and -E2; useful as vaccine or for diagnosis of non-A non-B hepatitis virus infection, or for concentrating or reducing HCV proteins in biological samples, and obtained by gene expression in yeast</title>
</analytic>
<monogr></monogr>
<series><title level="j">Vaccine</title>
<title level="j" type="abbrev">JVAC</title>
<idno type="ISSN">0264-410X</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1992">1992</date>
<biblScope unit="volume">10</biblScope>
<biblScope unit="issue">14</biblScope>
<biblScope unit="page" from="1060">1060</biblScope>
</imprint>
<idno type="ISSN">0264-410X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0264-410X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Amino acid sequence</term>
<term>Asialoglycoprotein</term>
<term>Atcc</term>
<term>Attenuated</term>
<term>Avipox</term>
<term>Avipox virus</term>
<term>Biological fluids</term>
<term>Biological samples</term>
<term>Cattle vaccine</term>
<term>Chiron</term>
<term>Continual introduction</term>
<term>Corresponding f1pv peptides</term>
<term>Culturing</term>
<term>Different genogroups serotypes</term>
<term>Distemper</term>
<term>Distemper virus</term>
<term>Distemper virus virogenetics world</term>
<term>Encoding</term>
<term>F1pv</term>
<term>Fecv</term>
<term>Fecv disease</term>
<term>Fecvj</term>
<term>Fecvj optionally</term>
<term>Feline corona virus</term>
<term>Fipv</term>
<term>Fipv exposures</term>
<term>Fipv strains</term>
<term>Fusion partner</term>
<term>Fusion protein expression unit</term>
<term>Galactokinase</term>
<term>Galanthus</term>
<term>Galanthus nivalus agglutinin</term>
<term>Gene expression</term>
<term>Gene segments encoding</term>
<term>Genogroups</term>
<term>Genome</term>
<term>Genomic</term>
<term>Genomic segments</term>
<term>Glycoprotein</term>
<term>Glycosylation</term>
<term>Glycosylation signal</term>
<term>Glycosylationdeficient</term>
<term>Glycosylationdeficient yeast</term>
<term>Haemagglutinin</term>
<term>Hepatitis virus infection</term>
<term>Hepatitis virus infections</term>
<term>Heterotypic</term>
<term>Heterotypic nonhuman animal rotavirus vaccine</term>
<term>Host animal inoculated</term>
<term>Host cell</term>
<term>Hrvs</term>
<term>Human rotavirus</term>
<term>Human rotaviruses</term>
<term>Immunological</term>
<term>Immunological response</term>
<term>Inoculated</term>
<term>Inoculating</term>
<term>Inst</term>
<term>Mannose</term>
<term>Mannose receptor</term>
<term>Measles</term>
<term>Measles virus</term>
<term>Measles virus glycoprotein</term>
<term>Measles virus haemagglutinin glycoprotein</term>
<term>Measles virus haemagglutinin glycoprotein measles virus fusion protein</term>
<term>Morbilli</term>
<term>Morbilli virus</term>
<term>Multiple serotypes</term>
<term>Native fipv exposure</term>
<term>Neutralizing</term>
<term>Neutralizing antibodies</term>
<term>Nivalus</term>
<term>Nonessential</term>
<term>Nonessential region</term>
<term>Nonhuman</term>
<term>Novel method</term>
<term>Novel rotaviruses</term>
<term>Novel vaccines</term>
<term>Optionally</term>
<term>Parental strains</term>
<term>Patent report virus disease</term>
<term>Peptide</term>
<term>Plasmid</term>
<term>Plasmid potskf3</term>
<term>Potskf3</term>
<term>Primary vaccination</term>
<term>Receptor</term>
<term>Recombinant</term>
<term>Recombinant expression</term>
<term>Recombinant protein</term>
<term>Recombinant vaccine</term>
<term>Regulator sequence</term>
<term>Regulatory sequence</term>
<term>Revaccinating</term>
<term>Rotavirus</term>
<term>Rotavirus illness</term>
<term>Rotavirus strains</term>
<term>Rutavirus</term>
<term>Rutavirus illnesses gamble inst</term>
<term>Selectable</term>
<term>Selectable marker</term>
<term>Serotypes</term>
<term>Sialylate</term>
<term>Sialylate glycoproteins</term>
<term>Structural gene encoding</term>
<term>Such vaccines</term>
<term>Tier</term>
<term>Vaccinated</term>
<term>Vaccinated animals</term>
<term>Vaccine</term>
<term>Vaccinia</term>
<term>Vaccinia virus</term>
<term>Virogenetics</term>
<term>Virus</term>
<term>Virus genome</term>
<term>Yeast chiron world</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list></list>
<tree></tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B45 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001B45 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= CovidV2 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:5B2F569956BF6BAE84DAF5C7D65E68D9BC1708F6 |texte= Hepatitis C virus asialoglycoprotein-E1 and -E2; useful as vaccine or for diagnosis of non-A non-B hepatitis virus infection, or for concentrating or reducing HCV proteins in biological samples, and obtained by gene expression in yeast }}
This area was generated with Dilib version V0.6.33. |